Pharmaceutical Mergers Under the Microscope: The FTC and Justice Department’s 2022 “Future of Pharmaceuticals” Workshop
This Briefing is brought to you by AHLA’s Antitrust Practice Group.
- November 08, 2023
- H. Kristie Xian , Jones Day
- Macklin Willigan , Jones Day
On June 1, 2023, the Federal Trade Commission (FTC) and the U.S. Department of Justice’s Antitrust Division (DOJ) issued a summary of their June 2022 virtual workshop, “The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers” (Workshop). This summary outlines how program participants—unified by their skepticism of pharmaceutical mergers and pro-enforcement perspectives—discussed new regulatory approaches to these mergers and provided recommendations “that will inform [the FTC’s] competition analysis and enforcement guidance in pharmaceutical markets going forward.”
ARTICLE TAGS
You must be logged in to access this content.